Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.
Related Research units
Abstract
Bibliographical data
Original language | English |
---|---|
Article number | 18 |
ISSN | 0732-183X |
Publication status | Published - 2011 |
pubmed | 21576635 |
---|